Rushing to higher concentrations before lower ones have demonstrated their effects leads to unnecessary escalation
Zhu, L., Zhou, J., Pan, Y., Lv, J., Liu, Y., Yu, S., & Zhang, Y
3,6 For the first time, we have evidence that semaglutide 2.4 mg improves cardiovascular outcomes in at-risk patients with BMI of 27 and above with established CVD, without diabetes, said Dr Michael Lincoff, lead study author, vice chair for research in the Cleveland Clinic Department of Cardiovascular Medicine, and a paid consultant for Novo Nordisk
The medication is well-studied with extensive long-term data supporting both its efficacy and safety profile
If compounded semaglutide ranges from approximately $200 to $500 per month, and that price difference enables you to stay on treatment, the accessibility tradeoff may be worth considering under medical supervision